Methotrexate Therapy in Rheumatoid Arthritis Current Status
- 1 August 1986
- journal article
- Published by Springer Nature in Drugs
- Vol. 32 (2), 103-113
- https://doi.org/10.2165/00003495-198632020-00001
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFENThe Lancet, 1986
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.Annals Of The Rheumatic Diseases, 1983
- No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic TumorsNew England Journal of Medicine, 1983
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978
- Chlorambucil and LeukemiaNew England Journal of Medicine, 1977
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973
- Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose RegimensBMJ, 1972
- THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITYThe Lancet Healthy Longevity, 1951